Results 101 to 110 of about 5,090,091 (161)

Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM. [PDF]

Circ Heart Fail
Kaski JP, Kantor PF, Nakano SJ, Olivotto I, Russell MW, Godown J, Chiu M, German P, Heitner SB, Jacoby DL, Kupfer S, Lutz J, Maharao N, Malik FI, Melloni C, Nieto Morales PF, Simkins T, Wei J, Ho CY, CEDAR-HCM Investigators.   +19 more
europepmc   +1 more source

Study design.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2021
openaire   +1 more source

Considerations for study design and analysis for ethically and culturally safe DNA methylation research in Aotearoa New Zealand. [PDF]

SSM Popul Health
Rolleston A, Jones GT, Earle NJ, Gibbs S, Pilbrow A, Faatoese A, Poppe KK, Henare K, Cameron VA, Macartney-Coxson D, Legget ME, Doughty RN.   +11 more
europepmc   +1 more source

Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics. [PDF]

Electrophoresis
Ries AB, Merkel MN, Coßmann K, Paul M, Grunwald R, Klemmer D, Hübner F, Eggensperger S, Weiß FT.   +8 more
europepmc   +1 more source

Outcomes in Symptomatic and Screen-detected Breast Cancer: Age, Tumor Biology, and Study Design Matter. [PDF]

Radiol Imaging Cancer
Tekcan Sanli DE, Sanli AN.
europepmc   +1 more source

The Wako Cohort Study: Design and Profile of Participants at Baseline. [PDF]

J Epidemiol
Yokoyama Y, Nofuji Y, Abe T, Nonaka K, Ozone Y, Nakamura Y, Chiaki S, Suda T, Saito N, Takase M, Amano H, Ogawa S, Suzuki H, Murayama H.   +13 more
europepmc   +1 more source